| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total revenue | 38,441 | 39,766 | 37,153 | 39,967 |
| Cost of revenue-Product | 19,204 | 20,022 | - | - |
| Cost of revenue | - | - | 30,111 | 26,762 |
| Cost of revenue-Service And Other | 3,078 | 4,853 | - | - |
| Amortization of acquired intangible assets | 183 | 183 | 4,345 | 3,201 |
| Loss on purchase commitment | 75 | 24 | 4,068 | - |
| Total cost of revenue | 22,540 | 25,082 | 38,524 | 29,963 |
| Gross profit | 15,901 | 14,684 | -1,371 | 10,004 |
| Research and development | 22,846 | 22,529 | 29,053 | 25,516 |
| Sales, general and administrative | 31,099 | 36,175 | 40,168 | 43,746 |
| Impairment charges | 0 | 0 | 15,000 | - |
| Amortization of acquired intangible assets | 833 | 833 | 362,042 | 3,649 |
| Change in fair value of contingent consideration | 0 | 0 | -18,700 | 1,170 |
| Total operating expense | 54,778 | 59,537 | 427,563 | 74,081 |
| Operating loss | -38,877 | -44,853 | -428,934 | -64,077 |
| Interest expense | 1,739 | 1,738 | 1,737 | 3,538 |
| Other income, net | 2,999 | 4,696 | 4,294 | 6,890 |
| Loss before income taxes | -37,617 | -41,895 | -426,377 | -60,725 |
| Income tax provision | 383 | 35 | -302 | - |
| Consolidated net loss | -38,000 | -41,930 | -426,075 | -60,725 |
| Unrealized gain (loss) on investments | 148 | -114 | -41 | 2,076 |
| Comprehensive loss | -37,852 | -42,044 | -426,116 | -58,649 |
| Basic (in dollars per share) | -0.13 | -0.14 | -1.44 | -0.22 |
| Basic (in shares) | 300,844,000 | 300,162,000 | 296,858,000 | 272,915,000 |
| Diluted (in dollars per share) | -0.13 | -0.14 | -1.44 | -0.22 |
| Diluted (in shares) | 300,844,000 | 300,162,000 | 296,858,000 | 272,915,000 |
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)